A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells
Top Cited Papers
- 22 May 2011
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 17 (6) , 738-743
- https://doi.org/10.1038/nm.2375
Abstract
Current approaches for analyzing the functional heterogeneity of immune cells include ELISPOT and flow cytometry. Chao Ma et al. have introduced an antibody-barcode microchip platform that enables the measurement of a large panel of secreted proteins from several hundred single cells or small cell colonies in parallel. The platform offers advantages over existing technologies in terms of cost, multiplexing capacity, types of proteins that can be measured and experiments performed. Cellular immunity has an inherent high level of functional heterogeneity. Capturing the full spectrum of these functions requires analysis of large numbers of effector molecules from single cells. We report a microfluidic platform designed for highly multiplexed (more than ten proteins), reliable, sample-efficient (∼1 × 104 cells) and quantitative measurements of secreted proteins from single cells. We validated the platform by assessment of multiple inflammatory cytokines from lipopolysaccharide (LPS)-stimulated human macrophages and comparison to standard immunotechnologies. We applied the platform toward the ex vivo quantification of T cell polyfunctional diversity via the simultaneous measurement of a dozen effector molecules secreted from tumor antigen–specific cytotoxic T lymphocytes (CTLs) that were actively responding to tumor and compared against a cohort of healthy donor controls. We observed profound, yet focused, functional heterogeneity in active tumor antigen–specific CTLs, with the major functional phenotypes quantitatively identified. The platform represents a new and informative tool for immune monitoring and clinical assessment.Keywords
This publication has 38 references indexed in Scilit:
- Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic MelanomaClinical Cancer Research, 2009
- Vaccination in Humans Generates Broad T Cell Cytokine ResponsesThe Journal of Immunology, 2004
- Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunityImmunobiology, 2004
- Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowNature Medicine, 2004
- Human CD8+ T-cell differentiation in response to virusesNature Reviews Immunology, 2003
- Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptorsNature Medicine, 2003
- Inflammation and cancerNature, 2002
- Toll-like receptors in the induction of the innate immune responseNature, 2000
- Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsNature Medicine, 1999
- Cluster analysis and display of genome-wide expression patternsProceedings of the National Academy of Sciences, 1998